The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Laudanosine     1-[(3,4- dimethoxyphenyl)methyl]- 6,7...

Synonyms: Veraisoquin, DL-Laudanosine, Prestwick_292, CHEMBL1407, ISO024, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of NSC35045


High impact information on NSC35045


Chemical compound and disease context of NSC35045


Biological context of NSC35045


Anatomical context of NSC35045


Gene context of NSC35045


Analytical, diagnostic and therapeutic context of NSC35045


  1. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Grigore, A.M., Brusco, L., Kuroda, M., Koorn, R. Crit. Care Med. (1998) [Pubmed]
  2. Effect of renal failure on laudanosine excretion in man. Fahey, M.R., Rupp, S.M., Canfell, C., Fisher, D.M., Miller, R.D., Sharma, M., Castagnoli, K., Hennis, P.J. British journal of anaesthesia. (1985) [Pubmed]
  3. Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Chapple, D.J., Miller, A.A., Ward, J.B., Wheatley, P.L. British journal of anaesthesia. (1987) [Pubmed]
  4. Electroencephalographic effects of laudanosine in an animal model of epilepsy. Tateishi, A., Zornow, M.H., Scheller, M.S., Canfell, P.C. British journal of anaesthesia. (1989) [Pubmed]
  5. Cardiovascular and electroencephalographic effects of laudanosine in "nephrectomized" cats. Ingram, M.D., Sclabassi, R.J., Cook, D.R., Stiller, R.L., Bennett, M.H. British journal of anaesthesia. (1986) [Pubmed]
  6. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma. Welch, R.M., Brown, A., Ravitch, J., Dahl, R. Clin. Pharmacol. Ther. (1995) [Pubmed]
  7. Pharmacokinetics and pharmacodynamics of atracurium obtained with arterial and venous blood samples. Donati, F., Varin, F., Ducharme, J., Gill, S.S., Théorêt, Y., Bevan, D.R. Clin. Pharmacol. Ther. (1991) [Pubmed]
  8. Pharmacology of laudanosine in dogs. Hennis, P.J., Fahey, M.R., Canfell, P.C., Shi, W.Z., Miller, R.D. Anesthesiology (1986) [Pubmed]
  9. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Eastwood, N.B., Boyd, A.H., Parker, C.J., Hunter, J.M. British journal of anaesthesia. (1995) [Pubmed]
  10. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage. Tassonyi, E., Fathi, M., Hughes, G.J., Chiodini, F., Bertrand, D., Muller, D., Fuchs-Buder, T. Acta anaesthesiologica Scandinavica. (2002) [Pubmed]
  11. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Bion, J.F., Bowden, M.I., Chow, B., Honisberger, L., Weatherley, B.C. Intensive care medicine. (1993) [Pubmed]
  12. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity. Katz, Y., Weizman, A., Pick, C.G., Pasternak, G.W., Liu, L., Fonia, O., Gavish, M. Brain Res. (1994) [Pubmed]
  13. Modification of central nervous system effects of laudanosine by inhalation anaesthetics. Shi, W.Z., Fahey, M.R., Fisher, D.M., Miller, R.D. British journal of anaesthesia. (1989) [Pubmed]
  14. Anaesthesia for the treatment of a giant cerebral aneurysm under hypothermic circulatory arrest. Thomas, A.N., Anderton, J.M., Harper, N.J. Anaesthesia. (1990) [Pubmed]
  15. Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits. Shi, W.Z., Fahey, M.R., Fisher, D.M., Miller, R.D., Canfell, C., Eger, E.I. Anesthesiology (1985) [Pubmed]
  16. Cerebrospinal fluid concentrations of laudanosine after administration of atracurium. Fahey, M.R., Canfell, P.C., Taboada, T., Hosobuchi, Y., Miller, R.D. British journal of anaesthesia. (1990) [Pubmed]
  17. Effect of atracurium and laudanosine on the release of 3H-noradrenaline. Kinjo, M., Nagashima, H., Vizi, E.S. British journal of anaesthesia. (1989) [Pubmed]
  18. Residual curarization in the neonate after caesarean section. Perreault, C., Guay, J., Gaudreault, P., Cyrenne, L., Varin, F. Canadian journal of anaesthesia = Journal canadien d'anesthésie. (1991) [Pubmed]
  19. Identification of laudanosine, an atracurium metabolite, following a fatal drug-related shooting. Logan, B.K., Case, G.A. Journal of analytical toxicology. (1993) [Pubmed]
  20. Nitrous oxide antagonizes CNS stimulation by laudanosine in mice. Avramov, M.N., Mori, K. British journal of anaesthesia. (1990) [Pubmed]
  21. Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle. Anselmi, E., Fayos, G., Blasco, R., Candenas, L., Cortes, D., D'Ocon, P. J. Pharm. Pharmacol. (1992) [Pubmed]
  22. Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation in pigs. Pittet, J.F., Tassonyi, E., Schopfer, C., Morel, D.R., Mentha, G., Fathi, M., Le Coultre, C., Steinig, D.A., Benakis, A. Anesthesiology (1990) [Pubmed]
  23. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome. Dhonneur, G., Cerf, C., Lagneau, F., Mantz, J., Gillotin, C., Duvaldestin, P. Anesth. Analg. (2001) [Pubmed]
WikiGenes - Universities